Answers are grounded in this paper and cite their sources.
Evaluates IOP reduction with trabecular micro-bypass stent in moderate to severe open-angle glaucoma, suggesting its potential role.
iStent inject® W appeared to provide meaningful IOP reduction and may serve as an intermediate option in patients with moderate-to-severe OAG. Early higher postoperative IOP may be an early response marker associated with surgical failure.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: